[Indoleamine 2, 3-dioxygenase activity during chemotherapy or trastuzumab therapy in patients with breast cancer].

Kenichi Sakurai, Shigeru Fujisaki, Saki Nagashima, Tetsuyo Maeda, Masahiko Shibata, Kenshi Gonda, Ryouichi Tomita, Shuhei Suzuki, Yukiko Hara, Katsuhisa Enomoto, Sadao Amano

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of '[Indoleamine 2, 3-dioxygenase activity during chemotherapy or trastuzumab therapy in patients with breast cancer].'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science